Sharps Technology’s SC Asset Purchase and $200 Million Syringe Sales Agreement Paves the Way to Begin Producing Prefillable Specialty Copolymer Syringes in the U.S.

May 31, 2024

https://www.globenewswire.com/news-release/2024/05/31/2891510/0/en/Sharps-Technology-s-SC-Asset-Purchase-and-200-Million-Syringe-Sales-Agreement-Paves-the-Way-to-Begin-Producing-Prefillable-Specialty-Copolymer-Syringes-in-the-U-S.html

Sharps CEO issues letter to shareholders with details about the InjectEZ acquisition, establishing Sharps position in the prefillable syringe (PFS) industry in the U.S. 

Signed Syringe Sales Agreement will secure product orders totaling over $200 million for the first five years of operation.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.